Related Experiment Video

Updated: Aug 4, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Targeted therapy for malignant melanoma

C K Brown1, J M Kirkwood

  • 1Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, 200 Lothrop Street, N-758 MUH, Pittsburgh, PA 15213-2582, USA.

Current Oncology Reports
|June 8, 2001
PubMed

Insights

This review explores three targeted melanoma therapies: immunotherapy, melanin synthesis targeting, and molecularly-driven strategies. These approaches aim to improve treatment efficacy and reduce toxicity for melanoma patients.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Melanoma treatment advances focus on reducing toxicity and increasing cancer cell death.
  • Targeted therapies offer a promising avenue for more effective melanoma management.

Purpose of the Study:

  • To review three distinct targeted therapy modalities for melanoma.
  • To highlight advancements in immunotherapy, metabolic targeting, and molecularly-driven treatments.

Main Methods:

  • Literature review of targeted melanoma therapy strategies.
  • Focus on mechanisms of action for immunotherapy, melanin synthesis inhibition, and molecularly targeted drugs.
  • Analysis of recent molecular biology findings related to melanoma development.

Main Results:

  • Immunotherapy harnesses the immune system to fight melanoma.
  • Targeting melanin synthesis pathways offers a specific approach to melanoma cell destruction.
  • Molecularly targeted therapies address genetic alterations driving melanoma growth.

Conclusions:

  • Multiple targeted therapy strategies are advancing melanoma treatment.
  • Understanding melanoma biology is key to developing novel and less toxic therapies.
  • Future directions include refining existing targeted treatments and exploring new molecular targets.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.